DIGE Digene Corp (MM)

GAITHERSBURG, Md., Nov. 13 /PRNewswire-FirstCall/ -- Digene Corporation (NASDAQ:DIGE), today announced that Evan Jones, Chairman and Chief Executive Officer, and Joseph Slattery, Chief Financial Officer, will be presenting at the Lehman Brothers Small Cap Conference on Friday, November 17, 2006 at 10:00 a.m. Pacific Standard Time. This conference will be held at the St. Regis Monarch Beach Hotel and Spa, Dana Point, California. A link to Lehman Brothers's live webcast and recording of Digene's presentation will be available on the Company's website, http://www.digene.com/. The recording of Digene's presentation will be available beginning approximately three hours after the live presentation ends, and will be archived until February 17, 2007. About Digene Digene Corporation (NASDAQ:DIGE), based in Gaithersburg, MD, develops, manufactures and markets proprietary DNA and RNA testing systems for the screening, monitoring and diagnosis of human diseases - with a focus on women's cancers and infectious diseases. The company's hc2 High-Risk HPV DNA Test(R) is the only test for human papillomavirus approved by the U.S. Food and Drug Administration (FDA), for both follow-up evaluation in women with inconclusive Pap results and for primary adjunctive screening with the Pap test in women age 30 and older. For primary adjunctive screening, it is marketed as both The Digene HPV Test and the DNAwithPap(R) Test. These brand names do not refer to the Digene product that tests for several types of the virus commonly referred to as "low-risk HPV," which are not associated with cervical cancer. For more information, visit http://www.thehpvtest.com/. Digene's HPV test is also CE-marked in Europe both routine, primary screening and follow-up evaluation of women with inconclusive Paps. It is marketed in more than 40 countries worldwide. In addition, Digene's product portfolio includes DNA tests for the detection of other sexually transmitted infections, including Chlamydia and gonorrhea, as well as tests for blood viruses. For more information, visit the company's Web site, http://www.digene.com/. Journalists may contact Pam Rasmussen, (301) 944-7196. DATASOURCE: Digene Corporation CONTACT: Investors - Albert Fleury, Investor Relations, Digene Corporation, +1-301-944-7000; or Investor Relations: Evan Smith, Financial Dynamics, +1-212-850-5606; or Media: Pam Rasmussen, Digene, +1-301-944-7196; or Sean Leous, Financial Dynamics, +1-212-850-5755 Web site: http://www.digene.com/

Copyright